Luncheon Symposium 27【Jianhe-Biomedical】

This lecture will present a 17-year journey of innovation, evidence generation, and public health implementation—from bench research to supporting global policy-making. The speaker will review the development of ShangRing male circumcision (MC) from its early clinical trials in China and Africa to its endorsement by WHO, USAID, PEPFAR, and UNAIDS, and its widespread adoption in voluntary medical male circumcision (VMMC) programs across sub-Saharan Africa. ShangRing remains the only MC device currently endorsed by the WHO for VMMC and HIV prevention in Africa.
 
The seasion will highlight how rigorous clinical and bench research, international collaboration, and surgical device innovation enabled ShangRing to become a safer, quicker, and more scalable solution for HIV prevention. Special emphasis will be placed on translational science—how evidence-based surgical device validation bridges innovation with global public health impact—offering a model for future interventions in surgical safety and global health-related clinical trials.
 
Safety remains the most critical consideration for public health-related surgical devices. In this context, data speaks volumes.